Human sLZIP promotes atherosclerosis via MMP-9 transcription and vascular smooth muscle cell migration
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jeonghan | - |
dc.contributor.author | Ko, Jesang | - |
dc.date.accessioned | 2021-09-05T03:23:12Z | - |
dc.date.available | 2021-09-05T03:23:12Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-11 | - |
dc.identifier.issn | 0892-6638 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/96882 | - |
dc.description.abstract | Atherosclerosis is a chronic inflammatory response of the vascular wall, and immune responses are involved in every phase of atherosclerosis, from initiation, to progression, and finally to plaque rupture. Cytokines are the major atherogenic mediators that promote plaque formation and progression by activation of inflammatory cells. They induce expressions of matrix metalloproteinases (MMPs), leading to vascular smooth muscle cell (VSMC) migration in atherosclerotic lesions. Although chronic inflammatory mediators, including tumor necrosis factor (TNF-) and MMPs, exacerbate atherosclerosis, the molecular mechanism of atherogenesis remains unclear. In this study we investigated the role of a novel transcription factor the human small leucine zipper protein (sLZIP) in TNF--induced MMP expression, VSMC migration, and atherosclerosis progression. The proinflammatory cytokine TNF- enhanced sLZIP expression by 3-fold via activation of NF-B signaling. sLZIP induced MMP-9 transcription and the proteolytic activity of MMP-9 by 2.8- and 3.2-fold (P< 0.05), respectively, in macrophages, leading to enhancement of VSMC migration by 2.7-fold (P<0.005). sLZIP(OE/+) (sLZIP transgenic); LDLR-/- mice fed a high-cholesterol diet exhibited enhanced arterial plaque formation and increased VSMC migration from the media into the intima by 2.8- and 2.6-fold (P<0.01), respectively, compared with atherosclerosis-prone LDLR-/- mice. These results indicate that human sLZIP plays a critical role in development of atherosclerosis and can be used as a therapeutic target molecule for treatment of atherosclerosis.Kim, J., Ko, J. Human sLZIP promotes atherosclerosis via MMP-9 transcription and vascular smooth muscle cell migration. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | FEDERATION AMER SOC EXP BIOL | - |
dc.subject | NECROSIS-FACTOR-ALPHA | - |
dc.subject | LEUCINE-ZIPPER PROTEIN | - |
dc.subject | E-DEFICIENT MICE | - |
dc.subject | MATRIX METALLOPROTEINASES | - |
dc.subject | DIFFERENTIALLY AFFECTS | - |
dc.subject | MACROPHAGES | - |
dc.subject | EXPRESSION | - |
dc.subject | MATRIX-METALLOPROTEINASE-9 | - |
dc.subject | DISEASE | - |
dc.subject | CYTOKINES | - |
dc.title | Human sLZIP promotes atherosclerosis via MMP-9 transcription and vascular smooth muscle cell migration | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Ko, Jesang | - |
dc.identifier.doi | 10.1096/fj.14-259218 | - |
dc.identifier.scopusid | 2-s2.0-84912050595 | - |
dc.identifier.wosid | 000344050900036 | - |
dc.identifier.bibliographicCitation | FASEB JOURNAL, v.28, no.11, pp.5010 - 5021 | - |
dc.relation.isPartOf | FASEB JOURNAL | - |
dc.citation.title | FASEB JOURNAL | - |
dc.citation.volume | 28 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 5010 | - |
dc.citation.endPage | 5021 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Life Sciences & Biomedicine - Other Topics | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | NECROSIS-FACTOR-ALPHA | - |
dc.subject.keywordPlus | LEUCINE-ZIPPER PROTEIN | - |
dc.subject.keywordPlus | E-DEFICIENT MICE | - |
dc.subject.keywordPlus | MATRIX METALLOPROTEINASES | - |
dc.subject.keywordPlus | DIFFERENTIALLY AFFECTS | - |
dc.subject.keywordPlus | MACROPHAGES | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | MATRIX-METALLOPROTEINASE-9 | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | CYTOKINES | - |
dc.subject.keywordAuthor | sLZIP | - |
dc.subject.keywordAuthor | matrix metalloproteinase | - |
dc.subject.keywordAuthor | vascular smooth muscle cell | - |
dc.subject.keywordAuthor | macrophage | - |
dc.subject.keywordAuthor | atherosclerosis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.